Discerning the role of bacteroides fragilis in celiac disease pathogenesis

Applied and Environmental Microbiology

Volumn 78, Issue 18, 2012, Pages 6507-6515

  Sanchez E ^a   Laparra, J M ^a   Sanz, Y ^a  

^a INSTITUTO DE AGROQUÍMICA Y TECNOLOGÍA DE ALIMENTOS CSIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE EFFECT; BACTEROIDES; BACTEROIDES FRAGILIS; CACO-2 CELLS; CELIAC DISEASE; CYTOKINE PRODUCTION; GASTROINTESTINAL DIGESTION; GELATINASE; HEALTHY CONTROLS; IN-CONTROL; IN-VIVO; INFLAMMATORY RESPONSE; METALLO-PROTEASE; METALLOPROTEASE GENE; METALLOPROTEASES; PROTEOLYTIC ACTIVITIES; TUMOR NECROSIS FACTOR ALPHA; VIRULENCE GENE; ZYMOGRAPHY;

CELL CULTURE; CLONING; GENES; MASS SPECTROMETRY; MONOLAYERS;

CELLS;

CYTOKINE; GLIADIN; METALLOPROTEINASE; VIRULENCE FACTOR;

BACTERIAL DISEASE; CLONE; ENZYME ACTIVITY; HEALTH RISK; IONIZATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PATHOGENICITY; PUBLIC HEALTH; VIRULENCE;

ARTICLE; BACTEROIDES FRAGILIS; BIOSYNTHESIS; CELIAC DISEASE; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; DRUG EFFECT; ELECTROSPRAY MASS SPECTROMETRY; ENZYMOLOGY; EPITHELIUM CELL; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PROTEIN DEGRADATION; TANDEM MASS SPECTROMETRY;

BACTEROIDES FRAGILIS; CACO-2 CELLS; CELIAC DISEASE; CELL MEMBRANE PERMEABILITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOKINES; EPITHELIAL CELLS; GLIADIN; HUMANS; METALLOPROTEASES; PROTEOLYSIS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TANDEM MASS SPECTROMETRY; VIRULENCE FACTORS;

BACTEROIDES; BACTEROIDES FRAGILIS; BACTEROIDES OVATUS; BACTEROIDES SP.;

EID: 84866152531     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.00563-12     Document Type: Article

References (47)

1. Barshack I, et al. 2001. Immunohistochemical analysis of candidate gene product expression in the duodenal epithelium of children with coeliac sprue. J. Clin. Pathol. 54: 684-688.
2. Basset C, Holton J, Bazeos A, Vaira D, Bloom S. 2004. Are Helicobacter species and enterotoxigenic Bacteroides fragilis involved in inflammatory bowel disease? Dig. Dis. Sci. 49: 1425-1432.
3. Bernardo D, et al. 2009. Is it true that coeliacs do not digest gliadin? Degradation pattern of gliadin in coeliac disease small intestinal mucosa. Gut 58: 886-887.
4. Botta GA, Arzese A, Minisini R, Trani G. 1994. Role of structural and extracellular virulence factors in gram-negative anaerobic bacteria. Clin. Infect. Dis. 18(Suppl 4): S260-S264.
5. Catassi C, et al. 2010. Natural history of celiac disease autoimmunity in a USA cohort followed since 1974. Ann. Med. 42: 530-538.
6. Cerdeno-Tarraga AM, et al. 2005. Extensive DNA inversions in the Bacteroides fragilis genome control variable gene expression. Science 307: 1463-1465.
7. Claros M, et al. 1995. Identification and strain differentiation of "Bacteroides fragilis group" species and Prevotella bivia by PCR fingerprinting. Anaerobe 1: 209-217.
8. Collado MC, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. 2009. Specific duodenal and faecal bacterial groups associated with paediatric coeliac disease. J. Clin. Pathol. 62: 264-269.
9. De Palma G, Nadal I, Collado MC, Sanz Y. 2009. Effects of a gluten-free diet on gut microbiota and immune function in healthy adult human subjects. Br. J. Nutr. 102: 1154-1160.
10. Dicksved J, et al. 2008. Molecular analysis of the gut microbiota of identical twins with Crohn's disease. ISME J. 2: 716-727.
11. Fasano A, Catassi C. 2005. Coeliac disease in children. Best Pract. Res. Clin. Gastroenterol. 19: 467-478.
12. Franco AA, et al. 1999. Molecular evolution of the pathogenicity island of enterotoxigenic Bacteroides fragilis strains. J. Bacteriol. 181: 6623-6633.
13. Franco AA, et al. 1997. Cloning and characterization of the Bacteroides fragilis metalloprotease toxin gene. Infect. Immun. 65: 1007-1013.
14. Hausch F, Shan L, Santiago NA, Gray GM, Khosla C. 2002. Intestinal digestive resistance of immunodominant gliadin peptides. Am. J. Physiol. Gastrointest. Liver Physiol. 283: G996-G1003.
15. Heap GA, van Heel DA. 2009. Genetics and pathogenesis of coeliac disease. Semin. Immunol. 21: 346-354.
16. Hoffman RA. 2000. Intraepithelial lymphocytes coinduce nitric oxide synthase in intestinal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 278: G886-G894.
17. Kato N, et al. 2000. A new subtype of the metalloprotease toxin gene and the incidence of the three bft subtypes among Bacteroides fragilis isolates in Japan. FEMS Microbiol. Lett. 182: 171-176.
18. Lammers KM, et al. 2008. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 135: 194-204.
19. Laparra JM, Glahn RP, Miller DD. 2009. Assessing potential effects of inulin and probiotic bacteria on Fe availability from common beans (Phaseolus vulgaris L.) to Caco-2 cells. J. Food Sci. 74: H40-H46.
20. Laparra JM, Sanz Y. 2010. Bifidobacteria inhibit the inflammatory response induced by gliadins in intestinal epithelial cells via modifications of toxic peptide generation during digestion. J. Cell Biochem. 109: 801-807.
21. Lidin-Janson G, et al. 1977. Comparison of Escherichia coli from bacteriuric patients with those from feces of healthy schoolchildren. J. Infect. Dis. 136: 346-353.
22. Lucke K, Miehlke S, Jacobs E, Schuppler M. 2006. Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis. J. Med. Microbiol. 55: 617-624.
23. Moncrief JS, Duncan AJ, Wright RL, Barroso LA, Wilkins TD. 1998. Molecular characterization of the fragilysin pathogenicity islet of enterotoxigenic Bacteroides fragilis. Infect. Immun. 66: 1735-1739.
24. Monteleone I, et al. 2010. Characterization of IL-17A-producing cells in celiac disease mucosa. J. Immunol. 184: 2211-2218.
25. Moron B, et al. 2008. Toward the assessment of food toxicity for celiac patients: characterization of monoclonal antibodies to a main immunogenic gluten peptide. PLoS One 3:e2294. doi:10.1371/journal. pone.0002294.
26. Nadal I, Donat E, Ribes-Koninckx C, Calabuig M, Sanz Y. 2007. Imbalance in the composition of the duodenal microbiota of children with coeliac disease. J. Med. Microbiol. 56: 1669-1674.
27. Patrick S, et al. 2010. Twenty-eight divergent polysaccharide loci specifying within- and amongst-strain capsule diversity in three strains of Bacteroides fragilis. Microbiology 156: 3255-3269.
28. Patrick S, et al. 2011. A unique homologue of the eukaryotic protein-modifier ubiquitin present in the bacterium Bacteroides fragilis, a predominant resident of the human gastrointestinal tract. Microbiology 157: 3071-3078.
29. Pumbwe L, Skilbeck CA, Wexler HM. 2006. The Bacteroides fragilis cell envelope: quarterback, linebacker, coach-or all three? Anaerobe 12: 211-220.
30. Rabizadeh S, et al. 2007. Enterotoxigenic Bacteroides fragilis: a potential instigator of colitis. Inflamm. Bowel Dis. 13: 1475-1483.
31. Resta-Lenert S, Barrett KE. 2006. Probiotics and commensals reverse TNF-α- and IFN-γ-induced dysfunction in human intestinal epithelial cells. Gastroenterology 130: 731-746.
32. Rhee KJ, et al. 2009. Induction of persistent colitis by a human commensal, enterotoxigenic Bacteroides fragilis, in wild-type C57BL/6 mice. Infect. Immun. 77: 1708-1718.
33. Rossi M, Schwartz KB. 2010. Editorial: celiac disease and intestinal bacteria: not only gluten? J. Leukoc. Biol. 87: 749-751.
34. Sakly W, Thomas V, Quash G, El AS. 2006. A role for tissue transglutaminase in alpha-gliadin peptide cytotoxicity. Clin. Exp. Immunol. 146: 550-558.
35. Sansonetti PJ. 2011. To be or not to be a pathogen: that is the mucosally relevant question. Mucosal Immunol. 4: 8-14.
36. Scotto d'Abusco AS, Del GM, Censini S, Covacci A, Pantosti A. 2000. The alleles of the bft gene are distributed differently among enterotoxigenic Bacteroides fragilis strains from human sources and can be present in double copies. J. Clin. Microbiol. 38: 607-612.
37. Sears CL. 2009. Enterotoxigenic Bacteroides fragilis: a rogue among symbiotes. Clin. Microbiol. Rev. 22: 349-369.
38. Shiba T, et al. 2003. The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. Microbiol. Immunol. 47: 371-378.
39. Skovbjerg H, Anthonsen D, Knudsen E, Sjostrom H. 2008. Deamidation of gliadin peptides in lamina propria: implications for celiac disease. Dig. Dis. Sci. 53: 2917-2924.
40. Sollid LM, Khosla C. 2005. Future therapeutic options for celiac disease. Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 140-147.
41. Swidsinski A, Loening-Baucke V, Herber A. 2009. Mucosal flora in Crohn's disease and ulcerative colitis: an overview. J. Physiol. Pharmacol. 60(Suppl 6): 61-71.
42. Sydora BC, et al. 2007. Epithelial barrier disruption allows non-diseasecausing bacteria to initiate and sustain IBD in the IL-10 gene-deficient mouse. Inflamm. Bowel Dis. 13: 947-954.
43. Takaishi H, et al. 2008. Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease. Int. J. Med. Microbiol. 298: 463-472.
44. Tothmeresz B. 1995. Comparison of different methods for diversity ordering. J. Vegetation Sci. 6: 283-290.
45. Vanhoutte T, et al. 2006. Molecular monitoring of the fecal microbiota of healthy human subjects during administration of lactulose and Saccharomyces boulardii. Appl. Environ. Microbiol. 72: 5990-5997.
46. Wexler HM. 2007. Bacteroides: the good, the bad, and the nitty-gritty. Clin. Microbiol. Rev. 20: 593-621.
47. Wu S, Lim KC, Huang J, Saidi RF, Sears CL. 1998. Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc. Natl. Acad. Sci. U. S. A. 95: 14979-14984.